According to authorities in China, a drug used in Japan to treat new strains of influenza has appeared to be effective in coronavirus patients.
An official at China’s science and technology ministry, said favipiravir, developed by a subsidiary of Fujifilm, had produced encouraging outcomes in clinical trials in Wuhan and Shenzhen involving 340 patients.
Patients who were given the medicine turned negative for the virus after an average of four days after becoming positive, compared with an average of 11 days for those who were not treated with the drug.
In addition, X-rays confirmed improvements in lung condition in about 91% of the patients who were treated with favipiravir, compared to 62% or those without the drug.
The prefect of the Alpes-Maritimes has made a legal challenge against new limits on large cruise ship moorings in Nice and Villefranche....
Read More
British Prime Minister Sir Keir Starmer and President Emmanuel Macron have announced a so-called "one in, one out" migrant deal aimed at reducing migr...
Read More
French comedian Bun Hay Mean, known as “le Chinois marrant,” has been found dead after an eight-story fall from his Paris apartment on the 10th of Jul...
Read More
French police have raided the headquarters of the far-right National Rally party as part of an inquiry into its campaign finances...
Read More
The massive wildfire near Marseille, which began on the 8th of July from a burning car on the A55, has burned over 700 hectares and destroyed or damag...
Read More
